No takes yet. Share an insight, caveat, or question.
Based on immigration and seroprevalence data, a significant number of chagasic cardiomyopathy cases (up to 29,409) are expected to emerge in Spain, highlighting the need for targeted screening.
Pérez‐Ayala et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: